Skip to main content
. 2022 Mar 28;35:10419. doi: 10.3389/ti.2022.10419

TABLE 2.

Relationship between preservation solutions and clinicopathological features of donors.

Total n = 380 UW n = 267 CS n = 83 HTK n = 7 IGL-1 n = 23 P
Age (years) 32 (21–40) 30 (20–39) 37 (29–45) 43 (33–47) 30 (19–39) 0.803a
0.042b
<0.001c
Gender M/F 224 (58.9)/156 (41.1) 164 (61.4)/103 (38.6) 45 (54.2)/38 (45.8) 4 (57.1)/3 (42.9) 11 (47.8)/12 (52.2) 0.266a
0.642b
0.251c
Cause of death
-Trauma 197 (51.8) 153 (57.3) 31 (37.3) 2 (28.6) 11 (47.8) 0.561a
-Anoxic damage 21 (5.5) 14 (5.2) 5 (6) - 2 (8.7) 0.100b
-CVA 146 (38.4) 90 (33.7) 44 (53) 4 (57.1) 8 (34.8) 0.012c
-Others 16 (4.2) 10 (3.7) 3 (3.6) 1 (14.3) 2 (8.7)
BMI (kg/m2) 23.4 (21.5–25.3) 23.2 (21.3–25.2) 23.4 (22.3 25.5) 24.2 (23.1–27.3) 23.6 (20.8–25.6) 0.839a
0.418b
0.065c
Pancreas CIT (hours) 10.1 (8–12) 10 (8–12) 11 (9–12.1) 8.3 (6–10.3) 8.2 (7.1–10.1) 0.001a
<0.001b
0.115c
Kidney CIT (hours) 12.3 (10–14.3) 12.3 (10–14.3) 12.8 (10.2–14.7) 10.8 (9.4–14.1) 11.2 (9.9–12.8) 0.262a
0.188b
0.600c
PPASS 16 (14–18) 16 (14–18) 17 (14–18) 17 (15–20) 17 (14–18) 0.637a
0.683b
0.043c
Perfusion Volume (L) 6.8 (6.0–7.4) 6.5 (6.0–7.0) 6 (5–6.1) 7 (6–7.5) 7.5 (7–8) 0.014a
0.002b
0.099c
Amylase (IU/L) 84 (47–164.2) 86 (48–172) 73 (39–146) 51 (39–63) 94 (57–294) 0.629a
0.202b
0.112c
Lipase (IU/L) 45 (17–109) 50 (20–126) 22 (11–85.5) 29 (8.2–55.7) 33 (6–79) 0.088a
0.820b
0.091c

Continuous variables are expressed as median (interquartile ranges) and categorical variables as frequencies (percentages).

Comparison of the analyzed variables have been made between UW, CS, and IGL-1, groups. For HTK, group only a descriptive analysis is displayed.

aIGL-1, vs. UW; bIGL-1, vs. CS; cUW, vs. CS.

M, indicates male; F, female; CVA, cerebrovascular accident; BMI, body mass index; CIT, cold ischemia time; PPASS, pre-procurement pancreas suitability score; UW, University of Wisconsin; CS, Celsior; HTK, Histidine-Tryptophan-Ketoglutarate; IGL-1, Institut Georges Lopez-1.